These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3740293)

  • 61. Artificial blood: current status of hemoglobin solutions.
    Gould SA; Sehgal LR; Sehgal HL; Moss GS
    Crit Care Clin; 1992 Apr; 8(2):293-309. PubMed ID: 1568141
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of peptide leukotrienes on cardiac dynamics in rat, cat, and guinea pig hearts.
    Roth DM; Lefer DJ; Hock CE; Lefer AM
    Am J Physiol; 1985 Sep; 249(3 Pt 2):H477-84. PubMed ID: 4037097
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments.
    Rudolph AS; Sulpizio A; Hieble P; MacDonald V; Chavez M; Feuerstein G
    J Appl Physiol (1985); 1997 Jun; 82(6):1826-35. PubMed ID: 9173947
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polymerized pyridoxylated hemoglobin: efficacy as an O2 carrier.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    J Trauma; 1986 Oct; 26(10):903-8. PubMed ID: 3772998
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vasoconstriction produced by intracoronary cholinomimetic drugs in isolated donor-perfused hearts of rhesus monkeys: comparison with pig, dog, and rabbit hearts.
    Sakai K
    J Cardiovasc Pharmacol; 1981; 3(3):500-9. PubMed ID: 6168831
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chronotropic effects of in vitro perfusion with albumin, stroma-free hemoglobin, and polyhemoglobin solutions.
    Walter SV; Chang TM
    Biomater Artif Cells Artif Organs; 1990; 18(2):283-98. PubMed ID: 2369651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma protein concentration and control of coronary vascular resistance in isolated rat heart.
    Avolio AP; Spaan JA; Laird JD
    Am J Physiol; 1980 Apr; 238(4):H471-80. PubMed ID: 7377317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tissue PO2 during reanimation with hemoglobin solutions.
    Messmer K; Jesch F; Endrich B; Hobbhahn J; Peters W; Schoenberg M
    Eur Surg Res; 1979; 11(3):161-71. PubMed ID: 510325
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ultra-pure polymerized bovine hemoglobin blood substitute: effects on the coronary circulation.
    Hodakowski GT; Page RD; Harringer W; Jacobs EE; LaRaia PJ; Svizzero T; Guerrero JL; Austen WG; Vlahakes GJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):669-72. PubMed ID: 1391493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased oxyhemoglobin affinity by carbamylation: coronary autoregulation and O2 transport.
    Baer RW
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H691-6. PubMed ID: 1415592
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resuscitation with pyridoxalated stroma free hemoglobin: tolerance to sepsis.
    Hoyt DB; Greenburg AG; Peskin GW; Forbes S; Reese H
    J Trauma; 1981 Nov; 21(11):938-42. PubMed ID: 7299862
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The quality control of stroma-free hemoglobin: lysophosphatidylcholine, a component of stromal phospholipids, as candidate vasoconstrictive factor.
    Matsuda N; Nakai K; Amano M; Takahashi TA; Ohta T; Sakuma I; Kitabatake A; Nakazato Y; Sekiguchi S
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):939-44. PubMed ID: 7994421
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coronary vascular actions of stroma-free hemoglobin preparations.
    Biro GP; Taichman GC; Lada B; Keon WJ; Rosen AL; Sehgal LR
    Artif Organs; 1988 Feb; 12(1):40-50. PubMed ID: 3355384
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Scope and limitations of stroma-free hemoglobin solution as an oxygen-carrying blood substitute.
    Palani CK; DeWoskin R; Moss GS
    Surg Clin North Am; 1975 Feb; 55(1):3-10. PubMed ID: 1118795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alpha-human atrial natriuretic peptide is a coronary vasodilator in the Langendorff-perfused guinea pig heart.
    Otero HO; Wangler RD; Sparks HV; Chimoskey JE
    Life Sci; 1988; 42(6):695-700. PubMed ID: 2963187
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Heme-containing proteins suppress lymphatic pumping.
    Wandolo G; Elias RM; Ranadive NS; Johnston MG
    J Vasc Res; 1992; 29(3):248-55. PubMed ID: 1504197
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synergistic toxicity of endotoxin and hemoglobin.
    White CT; Murray AJ; Smith DJ; Greene JR; Bolin RB
    J Lab Clin Med; 1986 Aug; 108(2):132-7. PubMed ID: 3525717
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of the properties of human hemoglobin covalently bound to carboxyl dextrans with free and polymerized hemoglobin.
    Pietta PG; Pace M; Palazzini G; Agostoni A
    Prep Biochem; 1984; 14(4):313-29. PubMed ID: 6083557
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enhanced oxygen unloading by an interdimerically crosslinked hemoglobin in an isolated perfused rabbit heart.
    Benesch R; Triner L; Benesch RE; Kwong S; Verosky M
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2941-3. PubMed ID: 6585838
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of o-raffinose-polymerized human hemoglobin on coronary tone and cardiac function in isolated hearts.
    Vogel WM; Cassidy G; Valeri CR
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):673-7. PubMed ID: 1391494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.